Medtronic Vascular
Clinical trials sponsored by Medtronic Vascular, explained in plain language.
Now part of
Medtronic plc
MDT
NYSE
A division of Medtronic specializing in vascular medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New balloon treatment for heart disease under study Results expected Feb 2027 (estimated)
- Tiny nerve zap could reveal secrets of blood pressure control Results expected Feb 2027 (estimated)
- 5,000-Patient registry tests kidney nerve procedure for Tough-to-Treat high blood pressure Results expected Jun 2027 (estimated)
- New shortcut for blood pressure treatment? Results expected Jun 2027 (estimated)